Point72 Asia (Singapore) Pte. Ltd. Vir Biotechnology, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 3,204 shares of VIR stock, worth $28,067. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,204Holding current value
$28,067% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VIR
# of Institutions
225Shares Held
88.2MCall Options Held
177KPut Options Held
182K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$146 Million1.67% of portfolio
-
Black Rock Inc. New York, NY16.6MShares$145 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA7.07MShares$61.9 Million0.0% of portfolio
-
Baillie Gifford & CO3.95MShares$34.6 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.16B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...